PharmaMar Articles
Zeltia's Yondelis approved for sale in 10 new countries
4 December 2012
UK’s NICE turns down PharmaMar’s Yondelis and GlaxoSmithKline’s Arzerra
20 September 2010
Showing 1-5 of 5 articles
- 1
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
